BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 29992382)

  • 1. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
    Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
    Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway.
    Do Carmo H; Arjun S; Petrucci O; Yellon DM; Davidson SM
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):165-168. PubMed ID: 29582211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Highly Selective Caspase-1 Inhibitor VX-765 Provides Additive Protection Against Myocardial Infarction in Rat Hearts When Combined With a Platelet Inhibitor.
    Yang XM; Downey JM; Cohen MV; Housley NA; Alvarez DF; Audia JP
    J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):574-578. PubMed ID: 28399648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
    Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor Does Not Protect Isolated Rat Hearts, Thus Clouding Its Proposed Cardioprotective Role Through ENT 1 in Heart Tissue.
    Yang XM; Gadde S; Audia JP; Alvarez DF; Downey JM; Cohen MV
    J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):371-376. PubMed ID: 30744423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes.
    Lieder HR; Braczko F; Gedik N; Stroetges M; Heusch G; Kleinbongard P
    Basic Res Cardiol; 2021 Apr; 116(1):27. PubMed ID: 33876304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart.
    Yang XM; Cui L; Alhammouri A; Downey JM; Cohen MV
    Cardiovasc Drugs Ther; 2013 Oct; 27(5):403-12. PubMed ID: 23832692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrially targeted Endonuclease III has a powerful anti-infarct effect in an in vivo rat model of myocardial ischemia/reperfusion.
    Yang XM; Cui L; White J; Kuck J; Ruchko MV; Wilson GL; Alexeyev M; Gillespie MN; Downey JM; Cohen MV
    Basic Res Cardiol; 2015 Mar; 110(2):3. PubMed ID: 25595210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts.
    Yang XM; Liu Y; Cui L; Yang X; Liu Y; Tandon N; Kambayashi J; Downey JM; Cohen MV
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):251-62. PubMed ID: 23233653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
    Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
    J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.
    Vessey DA; Li L; Honbo N; Karliner JS
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1429-35. PubMed ID: 19648253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts.
    Barrabés JA; Inserte J; Mirabet M; Quiroga A; Hernando V; Figueras J; Garcia-Dorado D
    Thromb Haemost; 2010 Jul; 104(1):128-35. PubMed ID: 20431845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preconditioning or Postconditioning with 8-Br-cAMP-AM Protects the Heart against Regional Ischemia and Reperfusion: A Role for Mitochondrial Permeability Transition.
    Khaliulin I; Ascione R; Maslov LN; Amal H; Suleiman MS
    Cells; 2021 May; 10(5):. PubMed ID: 34067674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels.
    Vessey DA; Li L; Kelley M
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H881-7. PubMed ID: 21685263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs.
    Vilahur G; Gutiérrez M; Casani L; Lambert C; Mendieta G; Ben-Aicha S; Capdevila A; Pons-Lladó G; Carreras F; Carlsson L; Hidalgo A; Badimon L
    Cardiovasc Res; 2018 Dec; 114(14):1860-1870. PubMed ID: 30124783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial.
    Ubaid S; Ford TJ; Berry C; Murray HM; Wrigley B; Khan N; Thomas MR; Armesilla AL; Townend JN; Khogali SS; Munir S; Martins J; Hothi SS; McAlindon EJ; Cotton JM
    Thromb Haemost; 2019 Jul; 119(7):1171-1181. PubMed ID: 31129911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels.
    Stroethoff M; Christoph I; Behmenburg F; Raupach A; Bunte S; Senpolat S; Heinen A; Hollmann MW; Mathes A; Huhn R
    J Cardiovasc Pharmacol; 2018 Aug; 72(2):106-111. PubMed ID: 29787401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction.
    Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
    Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
    Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.